Consolidated Statements of Cash Flows $ in Thousands	3 Months Ended	9 Months Ended
	Jun. 30, 2024 USD ($)	Jun. 30, 2024 USD ($)	Jun. 30, 2023 USD ($)
Operating activities:
Net increase (decrease) in net assets resulting from operations	$ 58,227	$ 167,638	$ 49,751
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash used in operating activities:
Net unrealized (appreciation) depreciation	3,198	(13,066)	(11,995)
Net realized (gains) losses	59	(3,741)	2,877
PIK interest income	(2,369)	(5,035)	(2,195)
Accretion of original issue discount on investments		(18,639)	(5,744)
Accretion of original issue discount on unsecured notes payable		221	0
Amortization of deferred financing costs		3,856	847
Amortization of deferred offering costs		694	2,517
Deferred taxes	2	2	(43)
Purchases of investments		(3,020,430)	(1,025,739)
Proceeds from the sales and repayments of investments		800,934	193,448
Changes in operating assets and liabilities:
(Increase) decrease in due from affiliates		861	(503)
(Increase) decrease in interest receivable		(20,326)	(6,453)
(Increase) decrease in receivables from unsettled transactions		(77,313)	(20,720)
(Increase) decrease in due from broker		(3,390)	0
(Increase) decrease in other assets		23	(147)
Increase (decrease) in accounts payable, accrued expenses and other liabilities		(444)	778
Increase (decrease) in base management fee and incentive fees payable		9,633	3,881
Increase (decrease) in due to affiliates		(4,695)	3,244
Increase (decrease) in interest payable		13,127	1,156
Increase (decrease) in payables from unsettled transactions		91,829	(6,477)
Net cash used in operating activities		(2,078,261)	(821,517)
Financing activities:
Distributions paid in cash		(113,935)	(34,531)
Borrowings under credit facilities		855,000	430,000
Repayments of borrowings under credit facilities		(40,000)	(180,000)
Issuance of unsecured notes		348,236	0
Proceeds from issuance of common shares		1,343,663	637,347
Deferred financing costs paid		(14,776)	(7,882)
Deferred offering costs paid		(855)	(143)
Share repurchases paid		(23,888)	0
Net cash provided by financing activities		2,353,445	844,791
Effect of exchange rate changes on foreign currency		(1,209)	(1,509)
Net increase (decrease) in cash and cash equivalents and restricted cash		273,975	21,765
Cash and cash equivalents and restricted cash, beginning of period		151,136	58,443
Cash and cash equivalents and restricted cash, end of period	425,111	425,111	80,208
Supplemental information:
Cash paid for interest		56,419	9,592
Non-cash financing activities:
Deferred financing costs incurred		538	307
Deferred offering costs incurred		162	645
Distribution payable		23,927	7,994
Reinvestment of dividends during the period	18,165	45,869	8,770
Shares repurchases accrued but not yet paid		16,736	40
Reconciliation to the Statement of Assets and Liabilities
Cash and cash equivalents	394,810	394,810
Restricted cash	30,301	30,301
Total cash and cash equivalents and restricted cash	$ 425,111	$ 425,111	$ 80,208